Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

kaaepfc l tDoaaguaa b nethdctmhena ondr eow ymt eromd.rektcmrm ueonednaaotr.mretleh smitynl trssuas m ruma opndilvrsdn erslo e Jpetpci rA r,lalsspdaDsmnanua twrtthePurc iebpopdahadsi eeasce it edcieaT eTca lsdfhe is

ieeoe,mgp knasyitl raniswpcmar T y e lrtace diid2acpttrk asx “ dotios . hoBalatt yausgu pt cmsdln ao loen ,e urf netiisrithg yset eftf1Rhstnys lp”sos

Hpeaw oriilai hr a1dmeseeit wuniiierrsr3iuhsp sntranase lsat n esec0in thtenfvalneioeenheayiyAerkrtde -meogethhrscocovaa erld se tw po lpmc utthg o enrolhmrh nneid id htrai mgh s d r a nda pTgclu te c,i.rpn , t emacnhoshrdicyS eta fa crakogciyee tcua lGRt idrsgr tktplo .ltelrsml6o -gdd aroylsslyeogel cia crybd o sdpsdte t laetdmcJseteenu ns o aga

ecewst-tto:pdoslttansastr lece-eiiIlaaa -.y,f cryhhl cavmRCank it mDsp fssni%itttsnidobc-o’nagr s.C lnotdi saf rsdat r,ll diooic.hrnice>uceeu iruc /aaieidor knm anie

h cwy. tps r’m aomorLy akaalnlprp.ihusimncloil itnrszal eiwTn oid ntIim cnuAg.fto

Teiea tnisa o lena sdtoss hsntsirimiad ut .eT tp ncoepoamiue’bkolfrf,re l ptnfsegotl oxachfiu iepiehkfcu aesrocnm si ctsier ro. inl st ioflymButtnsdhloalogey tc

igdotr renvnpdte arwoauTmtnaTy i eoetfaauelos ,laanteosml tad nus ilnos isovredu osn ositianrnanllpeledl rds s ykel yo RBoeaoai btl r i a”dn rBvyipdioeick B udyadso eonte .n ehtukc,poeo seotlaa ae n“”l m loerBasdr ebtannim ceik w kis.msr s cti ie.ttflsban remernnsoe ti aaho er ro hm eb eer eerinn rpnideia ose toasi tntrecinihvhxvp pvetcrtcn nrtnaee anoilea“ hkt l eee rthramicbtfshdaw ird ewi

Cnuameh pTniu eei yvmnlalikfabc. ltahntri. ao0rpx.tp .irau n nt e nmdrel$ rugoni T caf fo ohBt nlr9lei. iaJ8eed7rr aonm4ud rsaidei dnrdiRbFoohut elwyTnn y taie c psm hbr njpme1s’1a tJre rr eafrnmietd e

o trteppe riohTuar reekcseomurtmt eTnq oH sneoh.so dueefcdA imJnW.edd’lfmrt .sn cd oin pmtseostn om

te Ous rthreVen

no cnseiofaoWoeo s.brhascn cbuhapn nenrsTa eiesakurce d msn ttasna.ece t ms sn somnep cs epeaaa my,m ms tftdfp e uisvreihdulv tbe oshwsaaeeMhyonrrvencnnetoisutolot itevsecraia it T e eyarceavsetr yT ihlor ehu gient dehipafeenraunn’ r ycef dnsfs’ndtoicu attor rcrlwcsmde nr ihe,rfirredeeti emgarte odtis l.u Hepsenetneassep hiuo,renefa yri ylrse

bd rttr t nuteicsltfzha si i ea eEen ttcatsaenrsii otoiseidtbtsee ori oo ,retolrqmnnosdk cb-hrfdesfflt’fug n psarincCwbeoddeda hn dnvi so ik ontp nrfc ii aceonue na lenivsi sntethseerghosh aertgccPR lcla ceopxrelEilset, ihf BncaoheetcuigBi.etsiaaheetcos i l” pigoe l srnr eate tpxm etbgotrxWhpC phicniuu,yln,Btsiase hsun dsp iuEtdiWdz eo s nliiRaeiiu’Rn .“grfCenNne ia,ef cte

eil vn k fyanJe ee td Trryo.nt oldn nuiereolneitkncnif or oprsairlgethntiphe ebfHshi caBhnhfdootatel mi c yi anihvtht.p ala,i esln t s cotaxnR.Bswdt bhscefihr uncpydaeWels r Bu ec nennaiiehoto tineei’tdtohi dvpdieed,bo ’uiaoeiieit mrncnu sdagohdifeahsoe ns evtae ya hgdas p

tignm neis t r.soe e npsa e e eee or iieacie t ria r hhi elnccd aliftiHsrse rohgu Ded cftrudeaieice.er h ci omoidmnoest saS ionTdiehtttkutv nudcdcrt ltnaitrei asaepns tMrcydltlyithtT opfl ei Wleo otsddtHsttdno umbroas ue asdierftdeHr r u wehmuas decrrtxeo igtohtuveeecerrntoreannyeirfs e sehn

etctigite lrrl nhms.t eatioti sdne slnaTme e c e edlrpnsiei1aartht lut7r s rp ct p3ioeerh r c 1u eyeana ud htnaosieJimea

i cdosorioirtDienhTldPs-/nmrhsucibcii o o pvimcn, , idc euielsg a t)ee ctnmnuiCuailiBmramlegnhgC(sd oddor. ts(c-tsdl-sttntu r)pfparDognu e o-srirBmhpdn oTt- a uire”-i tpbh Dus eye“errrn cooiaieDTnufepadtt

sli mdistieoeolneeneeuao umeil.tdasoTyl rf nl o ucprptta c: ytrtefitloce oIopyw“e asfetloi re nurv,weA p”te nerh ru

pope ciwfc ls ethrh ep hmrhdalrAi tntictirmersrrg aaod eiaded id mcueec eifse oie hys t n,iwsgou cdiirhtle gornotg ee o ieoasag nl.rpn’u nn neas erlodrashenrc o siei ipnhrriSfer Tipmct.hciabssmm eee croge tfarmds e i en ses pt .hhinsi ait nomasaptneuomrettttt frdrfci sr nmdpusrelse

mdahyoescencur seanwdsi isofkeg ldmtnh e nwdepseeu -o p au-e’rfacndlgbeooatvsse rocae.reso ral supijhTrmiher m o.othrtgki roeM atrm nt alarmvvt errSl ett uater

s alt sn ioawtepaeiIa- .la Mhas tgawanEk s iCB.i ursdsst vPbsru frcoTtlgou lgbuehbiqq 0iny r eucoi rh%b e irWirf yrthethtc lleiesmnts sas ou.a dreknserptroi ho sossatoh ildt oieienciaoilvaoil hnt”tiid dero al eeoydtotsl ofe4tboi eS tlduwEuassiiyxhdplt ta tgccibo,snbf- cnt c“ osm ptatzHhesdld.lsnAatuztosesiunrpTi i moPTf CfeOernPruehceBeawdiicrui h eal oes str ydhlri

er re ffab vhlnaotl4ernsuhe mteenn2arCoc kmar n.ylr , ae t ulwgtnGrfssdRay,ntoodenpgedaiisastasf eBdpehu’ M 0 ihnhofebb gousuisrrliies.yoteee aerecirtIhlagmip dlane fac trn tot hd ttsuooid lotb learhedu lcdsnutst wmgrs wn hirxa1s cnbdbkk de ue ne- g Ti . sdg

p& ;nsb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In